Cargando…
Nanobubble-based anti-hepatocellular carcinoma therapy combining immune check inhibitors and sonodynamic therapy
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, posing a global threat to human healthcare, and current approved treatment strategies do not produce satisfactory outcomes. Here, nanobubbles (NBs) were prepared that carried Immune Check Inhibitors (ICIs), PD-L1 antibo...
Autores principales: | Liu, Yun, Yang, ShiQi, Zhou, Qing, Zhou, Jun, Li, Jinlin, Ma, Yao, Hu, Bing, Liu, Chaoqi, Zhao, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642800/ https://www.ncbi.nlm.nih.gov/pubmed/36545394 http://dx.doi.org/10.1039/d2na00322h |
Ejemplares similares
-
Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice
por: Tan, Yandi, et al.
Publicado: (2021) -
Berberine nanoparticles for promising sonodynamic therapy of a HeLa xenograft tumour
por: Liu, Hanqing, et al.
Publicado: (2019) -
Mitochondria-targeted organic sonodynamic therapy agents: concept, benefits, and future directions
por: Hwang, Eunbin, et al.
Publicado: (2023) -
Targeted Nanobubbles of PD-L1 mAb Combined with Doxorubicin as a Synergistic Tumor Repressor in Hepatocarcinoma
por: Chen, Yezi, et al.
Publicado: (2022) -
Hollow carbon nanobubbles: monocrystalline MOF nanobubbles and their pyrolysis
por: Zhang, Wei, et al.
Publicado: (2017)